Alligator Bioscience AB (LTS:0RK9)
kr 1.256 0 (0%) Market Cap: 934.77 Mil Enterprise Value: 869.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q4 2021 Alligator Bioscience AB Earnings Call Transcript

Feb 11, 2022 / 02:30PM GMT
Release Date Price: kr0.942198
Operator

(audio in progress) Relations.

Julie Silber
Alligator Bioscience AB - Senior Director, Communications & IR

Thank you, Simon. Hello, and welcome to Alligator Bioscience year-end 2021 call. This is Julie Silber, Senior Director of Communications and Investor Relations, and I will introduce today's call. On the call with me today is CEO Søren Bregenholt; and CFO Marie Svensson. After a brief company statement by management, we will open up the call for Q&A.

Before we begin, I would like to share a quick reminder to our listeners that during today's call, management may make forward-looking statements that involve known and unknown risks, uncertainties and other important factors beyond the company's control that could cause the company's actual results, performance, or achievements to be materially different from the expected results, performance or achievements expressed or implied by such forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those contained

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot